Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Increase in Short Interest

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the recipient of a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 8,400 shares, a growth of 250.0% from the September 30th total of 2,400 shares. Based on an average trading volume of 48,900 shares, the short-interest ratio is currently 0.2 days.

Ocean Biomedical Price Performance

OCEAW stock remained flat at $0.05 on Friday. The company had a trading volume of 8,498 shares, compared to its average volume of 43,124. The company has a fifty day moving average of $0.04 and a two-hundred day moving average of $0.06. Ocean Biomedical has a 52-week low of $0.02 and a 52-week high of $0.70.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.